Pharmafile Logo

Aqurance

Aqurance consults Life Sciences industry to empower with digital solutions their salesforce, implementing top quality technology platforms, through its strategic partnerships. Founded in September 2011, with offices in Athens and Istanbul, is the fastest growing service provider for Life Sciences in South East Europe.
We believe that the future of Pharma is evidence-based. Our mission is to provide and implement effective tools that will help industry professionals make better and more effective decisions. We aim to facilitate Pharma managers in successfully overcoming budgetary and organizational challenges by using technology and data combined.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Egiou 1 & Figaleias Athens, Bilim Sokak Sun Plaza Kat: 13 Istanbul, Greece - Turkey, 14564 - 34398
+30 210 6200 206 - +90 212 366 02 40

 Latest Content from PMHub 

J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment

Press Releases | June 17, 2026 | Uniphar

Strategic partnership enables direct progression to Phase 3, bypassing additional Phase 2 study, as first patients are randomized in global trial  TOKYO, Japan and DUBLIN, Ireland — [June 16, 2026] J‑Pharma Co., Ltd., a clinical-stage biotechnology...

Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education

Medscape Education has been recognized with 2 prestigious accolades at the Spring 2026 Digital Health Awards. The premier digital education platform earned a Gold Award for its PIONEER initiative in...

How to build a commercialisation strategy fit for biopharma’s new evidence era

The bar for evidence has never been higher. The EU's Joint Clinical Assessment process went live in January 2025, introducing harmonised clinical evidence requirements across member states. Regulators are demanding...

New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates

A new benchmark maps 100 UK prescription medicine companies across five maturity bands and finds a market at very different stages of digital development

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

The words around health matter

Press Releases | June 4, 2026 | Mednet

The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma and support better real-world healthcare...

From activity to impact: 5 takeaways from MAPS Americas 2026

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now...

Medscape Education Brings AI to the Hematology Frontline at EHA 2026

Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.

Where it all began – why we developed The Experience Gap

Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, and driving better recruitment and...

What do HCPs want from pharma medical information sites in 2026?

At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector...